Interleukin-40 as a biomarker of mortality risk in patients with severe pneumonia.

Saved in:
Bibliographic Details
Title: Interleukin-40 as a biomarker of mortality risk in patients with severe pneumonia.
Authors: Tan H; Department of Blood Transfusion, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China., Wang H; Key Laboratory of Diagnostic Medicine Designated by the Ministry of Education, Chongqing Medical University, Chongqing, China., Zhou X; Department of Blood Transfusion, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China., Duan J; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China., Yang X; Department of Blood Transfusion, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Source: Frontiers in immunology [Front Immunol] 2026 May 28; Vol. 17, pp. 1804357. Date of Electronic Publication: 2026 May 28 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2026.1804357